Opus Genetics (IRD) Non-cash Items (2011 - 2020)
Opus Genetics (IRD) reported Non-cash Items of $102939.0 for Q3 2020, down 15.73% year-over-year from $122150.0 in Q4 2019, and up 4.15% quarter-over-quarter from $98834.0 in Q2 2020.
Opus Genetics (IRD) Non-cash Items (2011 - 2020) Analysis & Trends
Opus Genetics (IRD) has 10 years of Non-cash Items data on file, last reported at $102939.0 in Q3 2020.
- Non-cash Items for Q3 2020 came in at $102939.0, down 15.73% year-over-year; the trailing twelve-month figure through Sep 2020 was $102939.0 (down 15.73% YoY), and the FY2019 annual result was $123263.0, down 91.75% from the prior year.
- Non-cash Items grew to $102939.0 in Q3 2020 per IRD's latest filing, from $98834.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $10.3 million in Q1 2017 and troughed at $53883.0 in Q4 2017.
- A 5-year average of $2.6 million and a median of $342455.0 in 2017 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2016 and 2017: Non-cash Items surged 29821.43% in 2016, then plunged 99.32% in 2017.
- A 5-year view of Non-cash Items shows it stood at $7.9 million in 2016, then sank by 99.32% to $53883.0 in 2017, then soared by 2671.5% to $1.5 million in 2018, then tumbled by 91.75% to $123263.0 in 2019, then decreased by 16.49% to $102939.0 in 2020.
- Business Quant data shows IRD's Non-cash Items at $102939.0 in Q3 2020, $98834.0 in Q2 2020, and $75304.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Opus Genetics | 355.39 Mn | 295.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 102,939.00 |
| Sep 30, 2020 | 102,939.00 |
| Jun 30, 2020 | 98,834.00 |
| Jun 30, 2020 | 98,834.00 |
| Mar 31, 2020 | 75,304.00 |
| Mar 31, 2020 | 75,304.00 |
| Dec 31, 2019 | 123,263.00 |
| Dec 31, 2019 | 123,263.00 |
| Sep 30, 2019 | 122,150.00 |
| Sep 30, 2019 | 122,150.00 |
| Jun 30, 2019 | 119,953.00 |
| Jun 30, 2019 | 119,953.00 |
| Mar 31, 2019 | 138,292.00 |
| Mar 31, 2019 | 138,292.00 |
| Dec 31, 2018 | 1.49 Mn |
| Dec 31, 2018 | 1.49 Mn |
| Sep 30, 2018 | 1.35 Mn |
| Sep 30, 2018 | 1.35 Mn |
| Jun 30, 2018 | 1.32 Mn |
| Jun 30, 2018 | 1.32 Mn |